• 1. Lloyd-Jones DM., et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110(9):1042-46.
  • 2. Camm AJ., et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. Eur Heart J. 2012;33(21):2719-47.
  • 3. National Heart, Lung, and Blood Institute. What Is Atrial Fibrillation? http://www.nhlbi.nih.gov/health/dci/Diseases/af/af_what.html Last accessed January 2016.
  • 4. National Heart, Lung, and Blood Institute. Signs and Symptoms of Atrial Fibrillation? http://www.nhlbi.nih.gov/health/health-topics/topics/af/signs.html Last accessed January 2016.
  • 5. National Heart, Lung, and Blood Institute. Types of Strokes. http://www.nhlbi.nih.gov/health/health-topics/topics/stroke/types.html Last accessed January 2016.
  • 6. Aguilar MI, Hart R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database of Syst Rev. 2005;(3):CD001927.
  • 7. Kannel WB & Benjamin EF. Status of the epidemiology of atrial fibrillation. Med Clin North Am. 2008;92(1):17-40.
  • 8. Fuster V. et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation – executive summary. Circulation. 2006;114:700-52.
  • 9. Graham DJ et al, Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation. Circulation. 2015 Jan 13;131(2):157-64.
  • 10. Lip GY, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 2010;137:263–272.
  • 11. Healey JS, et al. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial. Circulation. 2012 Jul 17;126(3):343-8.
  • 12. Connolly SJ. et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-51.
  • 13. Granger et al. Apixaban vs Warfarin in Patients with atrial fibrillation. N Engl J Med. 2011:981-92.